T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.
Anthony T RederOlaf StüveStephanie K TankouThomas P LeistPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Studies of COVID-19 immunity in people with MS on DMTs should ideally include comprehensive assessment of innate, humoral, and T cell responses.